Cargando…
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
NKp46 is a major determinant of natural killer (NK) cell function and it is implicated in tumor immune surveillance in acute myeloid leukemia (AML). The purpose of this study was to investigate the prognostic significance of NKp46 expression in an independent cohort of patients with AML, and to inve...
Autores principales: | Chretien, Anne-Sophie, Devillier, Raynier, Fauriat, Cyril, Orlanducci, Florence, Harbi, Samia, Le Roy, Aude, Rey, Jérôme, Bouvier Borg, Gaelle, Gautherot, Emmanuel, Hamel, Jean-François, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Blaise, Didier, Olive, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706596/ https://www.ncbi.nlm.nih.gov/pubmed/29209559 http://dx.doi.org/10.1080/2162402X.2017.1307491 |
Ejemplares similares
-
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017) -
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2019) -
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017) -
Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015) -
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
por: Chretien, Anne-Sophie, et al.
Publicado: (2021)